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Background: The aim of present study was to develop the novel methods for chemical and physical modification
of superparamagnetic iron oxide nanoparticles (SPIONs) with polymers via covalent bonding entrapment. These
modified SPIONs were used for encapsulation of anticancer drug doxorubicin.
Method: At first approach silane–grafted magnetic nanoparticles was prepared and used as a template for
polymerization of the N-isopropylacrylamide (NIPAAm) and methacrylic acid (MAA) via radical polymerization. This
temperature/pH-sensitive copolymer was used for preparation of DOX–loaded magnetic nanocomposites. At
second approach Vinyltriethoxysilane-grafted magnetic nanoparticles were used as a template to polymerize
PNIPAAm-MAA in 1, 4 dioxan and methylene-bis-acrylamide (BIS) was used as a cross-linking agent. Chemical
composition and magnetic properties of Dox–loaded magnetic hydrogel nanocomposites were analyzed by FT-IR,
XRD, and VSM.
Results: The results demonstrate the feasibility of drug encapsulation of the magnetic nanoparticles with NIPAAm–
MAA copolymer via covalent bonding. The key factors for the successful prepardtion of magnetic nanocomposites
were the structure of copolymer (linear or cross-linked), concentration of copolymer and concentration of drug. The
influence of pH and temperature on the release profile of doxorubicin was examined. The in vitro cytotoxicity test
(MTT assay) of both magnetic DOx–loaded nanoparticles was examined. The in vitro tests showed that these
systems are no toxicity and are biocompatible.
Conclusion: IC50 of DOx–loaded Fe3O4 nanoparticles on A549 lung cancer cell line showed that systems could be
useful in treatment of lung cancer.
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Functionalization of nanomaterials with chemical or bio-
logical molecules exhibits novel properties for various likely
applications. The distinctive physico-chemical properties of
these materials when utilized in conjunction with the
remarkable biomolecular recognition capabilities could lead
to miniature biological, optical and electronics devices [1,2].
However, an essential issue for in vivo application is its
biocompatibility. Central focus to tackling this problem is
surface modification of nanomaterials to prevent the
spontaneous aggregation and elucidating the interface
between nanomaterials and biosystem. Among inorganic
nanomaterials, iron oxide nanoparticles (IOPs) have a high
potential for the use in a lot of in vitro and in vivo
applications. Based on their unique mesoscopic physical,
chemical, thermal, and mechanical properties, IOPs offer a
high potential for several biomedical applications such
as: [3,4].
(1) cellular therapy, cell labelling, and targeting as a tool
for cell-biology research (2) tissue repair (3) drug delivery
(4) magnetic resonance imaging (MRI); (5) hyperthermia;
(6) magnetofection; etc. For these applications
surfaces modification of the nanoparticles by creating
a few atomic layer of organic (e.g. polymers) or inorganic
(e.g. gold) material or oxide surfaces (e.g. silica or alumina)
could be an excellent job for the further functionalization
with various bioactive molecules. MNPs may soon play
a significant role in meeting the healthcare requirements
of tomorrow.
A significant challenge associated with the application
of these MNP systems is their behavior in-vivo. The effi-
cacy of many of these systems is often compromised due
to recognition and clearance by the reticuloendothelial
system (RES) prior to reaching target tissue, as well as
by an inability of to overcome biological barriers, such
as the vascular endothelium or the blood brain barrier.Figure 1 Applications of superparamagnetic iron oxide nanoparticlesThe fate of these MNP upon intravenous administration
is highly dependent on their size, morphology, charge
and surface chemistry. These physicochemical properties
of nanoparticles directly affect their subsequent pharma-
cokinetics and biodistribution. To increase the effective-
ness of MNPs, several techniques, including: reducing
size and grafting non-fouling polymers have been
employed to improve their “stealthiness” and increase
their blood circulation time to maximize the likelihood
of reaching targeted tissues [5,6].
The major disadvantage of most chemotherapeutic
approaches to cancer treatment is that most of them are
non-specific. Therapeutic (generally cytotoxic) drugs are
administered intravenously leading to general systemic
distribution (Figure 1). The non-specific nature of this
technique results in the well-known side effects of
chemotherapy as the cytotoxic drug attacks normal,
healthy cells in addition to its primary target and tumor
cells [7,8]. Magnetic nanoparticles (MNPs) can be used
to overcome this great disadvantage. Nanoparticle can
be used to treat tumors in three different ways: (i) spe-
cific antibodies can be conjugated to the MNPs to
selectively bind to related receptors and inhibit tumor
growth; (ii) targeted MNPs can be used for hyperthermia
for tumor therapy; (iii) drugs can be loaded onto the
MNPs for targeted therapy [9-11]. The targeted delivery
of anti-tumor agents adsorbed on the surface of MNPs
is a promising alternative to conventional chemotherapy.
The particles loaded with the drug are concentrated at
the target site with the aid of an external magnet. The
drugs are then released on the desired area [12]. Mag-
netic particles smaller than 4 μm are eliminated by cells
of the RES, mainly in the liver (60–90%) and spleen
(3–10%). Particles larger than 200 nm are usually
filtered to the spleen, whose cut-off point extends up
to 250 nm. Particles up to 100 nm are mainly phagocytosed(SPION)10.
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the shorter their plasma half-life-period [13].
Functionalization of MNPs with amino group, silica,
polymer, various surfactants or other organic compounds is
usually provided in order to achieve better physicochemical
properties. Moreover, the core/shell structures of MNPs
have the advantages of good dispersion, high stability
against oxidation and appreciable amount of drug can be
loaded to the polymer shell. Furthermore, lots of functional
groups from polymers on the surface can be used for
further functionalization to get various properties [14]. It is
favored that MNPs retain sufficient hydrophilicity with
coating, do not exceed 100 nm in size to avoid rapid
clearance by reticuloendothelial system (RES) [15]. It
was found the surface functionalization plays also the
key role in nanoparticle toxicity [16].
It was found the surface functionalization plays also
the key role in nanoparticle-toxicity.In this research
we intend to investigate the in vitro characteristics of
our nanoparticles for drug delivery applications [17].
Of these temperature-sensitive polymer-grafted MNPs,
poly-(N-isopropylacrylamide) (PNIPAAm)-grafted MNPs
are of particular interest because of their stimuli
(temperature) responsiveness and enhanced drug-loading
ability. These characteristics are due to their large inner
volume, amphiphilicity, capacity for manipulation of
permeability, and response to an external temperature
stimulus with an on-off mechanis [18-20]. However,
one potential problem with using PNIPAAm as a
polymer coat is that its lower critical solution
temperature (LCST), the temperature at which a
phase transition occurs, is below body temperature
(32C). To increase the LCST of PNIPAAm above
body temperature, it has been co-polymerized with
different monomers (Figure 2) [21,22].Figure 2 Structure of the PNIPAAm-MAA copolymer.To manufacture the PNIPAAm-MAA-grafted Magnetic
nanoparticles, two synthetic steps were used [23]. First,
magnetic nanoparticles were covalently bound with a silane
coupling agent, vinyltriethoxysilane (VTES), to produce a
template site for a radical polymerization. NIPAAm and
MAA were then polymerized on the silicon layer around
the magnetic nanoparticles via methylene-bis-acrylamide
and ammonium persulfate as a cross-linking agent and an
initiator, respectively. The resultant particles were
characterized by X-ray powder diffraction (XRD), Scanning
electron microscopy (SEM), Fourier transform infrared
spectroscopy (FT-IR), and vibrating sample magnetometry
(VSM). The in-vitro cytotoxicity test for the PNIPAAm-
MAA-grafted magnetic nanoparticles was analyzed. The
drug release behavior of doxorubicin (an anticancer drug
model) from the nanoparticles at various pH and at diffe-
rent temperatures below and at the lower critical solution
temperature (LCST) was also analyzed. Being able to moni-
tor the location of the drug-loaded nanoparticles after
administration proved to be a considerable advantage in
cases such as cancer therapy, in which the drug has serious
side effects on healthy tissues [24,25].
Materials and methods
Materials
Ferric chloride hexahydrate (FeCl3.6H2O), Ferrous
chloride tetrahydrate (FeCl2. 4H2O) and ammonium
hydroxide (25 wt.%) were purchased from Fluka
(Buchs, Switzerland). 1,4 dioxan, Ammonium persulfate,
AIBN(2 Azo Bis Iso Butyro Nitrile), MAA, NIPAAm, and
DMSO , methylene-bis-acrylamide (BIS), VTES, acetic acid,
ethanol were purchased from Sigma-Aldrich (St. Louis,
Missouri) . Doxorubicin hydrochlorid was purchased from
Sigma-Aldrich. XRD, Rigaku D/MAX-2400 X-ray diffract-
ometer with Ni-filtered Cu Kα radiation, scanning electron
microscopy (SEM) measurements were conducted using a
VEGA/TESCAN. The drug loading capacity and release
behavior were determined using a UV–vis 2550 spectro-
meter (Shimadzu). The infrared spectra of copolymers
were recorded on a Perkin Elmer 983 IR spectrometer
(Perkin Elmer, USA) at room temperature. The magnetic
property was measured on VSM/AGFM (Meghnatis
Daghigh Kavir Co Iran) vibrating sample magnetometer
at room temperature. The drug loading capacity and
release behavior were determined using a UV–vis
2550 spectrometer (Shimadzu). The organic phase was
evaporated by rotary (Rotary Evaporators, Heidolph
Instruments, Hei-VAP Series).
Preparation of superparamagnetic magnetite
nanoparticles
Superparamagnetic magnetite nanoparticles (MNPs)
were prepared via improved chemical co-precipitation
method [26]. According to this method, 3.17 g of
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(0.008 mol) were dissolved in 50 ml of deionized
water, such that Fe2+/Fe3+ = 1/2. The mixed solution
was stirred under N2 at 85C for 1 h (Figure 3).
Then, 40 ml of NH3 · H2O was injected into the
mixture rapidly, stirred under N2 for another 1 h and
then cooled to room temperature. The precipitated
particles were washed several times with hot water
and separated by magnetic decantation. Finally, magnetic
MNPs were dried under vacuum at 65C.Synthesis of Silane–grafted magnetic nanoparticles for
loading of doxorubicin
Synthesis of VTES-grafted magnetic nanoparticles
VTES-modified magnetite nanoparticles were synthesised
by the reaction between VTES and the hydroxyl groups
on the surface of magnetite. Nearly, 2 g of Fe3O4
nanoparticles were dispersed in 100 ml of ethanol by
sonication for about 1 h, then 24 ml of NH3.H2O
was added and sonicated to homogenize for 12 min.
Under continuous mechanical stirring, 10 ml of
VTES was added to the reaction mixture. The reac-
tion was allowed to proceed at 60C for 6 h under
continuous stirring. The resultant products were
obtained by magnetic separation with permanent
magnet and were thoroughly washed with ethanol
and deionized water until neutral, then were dried at
room temperature under vacuum for 24 h.Figure 3 Magnetite-hexane suspension attached to a magnet.Copolymerization of PNIPAAm-MAA on the surface of VTES-
grafted magnetic nanoparticles
The graft polymerization was conducted under various re-
action conditions. VTES-grafted magnetic nanoparticles
were used as a template to polymerize PNIPAAm-MAA in
a 1, 4 dioxan. BIS was used as cross-linking agent. In brief,
0.06 g of VTES-grafted magnetic nanoparticles, 0.3 g of
NIPAAm, 0.026 g of MAA and 0.027 g of BIS were
sonicated in 200 ml cold water for 50 minutes. Then,
0.16 g of ammoniumpersulfate was added to the solution,
and the reaction was carried out at room temperature
under N2 gas for 10 hours. The product was purified
several times with deionized water by using a magnet to
collect only PNIPAAm-MAA-grafted magnetic nano-
particles. PNIPAAm-grafted magnetic nanoparticles were
also formulated using the same synthesis process as with
PNIPAAm-MAA-grafted magnetic nanoparticles, but
without addition of MAA monomers (Figure 4) [27].
Drug-loading of the PNIPAAm-MAA-grafted magnetic
nanoparticles
For drug-loading doxorubicin was used as a model drug.
In brief, 2 mg of freeze-dried PNIPAAm-MAA-grafted
magnetic nanoparticles and 2 mg of doxorubicin were
dispersed in 30 ml phosphate buffer solution (PBS). The
solution was stirred at 4C for 2 days. The doxorubicin-
loaded PNIPAAm-MAA-grafted magnetic nanoparticles
were separated from the solution using an external magnet.
The solution was then analyzed using an ultraviolet-visible
Figure 4 (A) Chemical modification of Fe3O4 surface by grafting polymerization without cross-linking (B) In presence of cross-linking.
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the amount of unencapsulated doxorubicin (λex 470 nm
and λem 585 nm). This value was then compared to the
total amount of added doxorubicin to determine the
doxorubicin-loading efficiency of the nanoparticles [28].In vitro drug release
To study drug release, four different sets of experiments
were performed. They include two different temperatures
(40 and 37C) and two different pHs (5.8 and 7.4). In each
drug release experiment, 3.0 mg of the drug carrier
bonded with smart polymer was sealed in a 30 ml of
Na2HPO4– NaH2PO4 buffer solution with pH of 5.8
or 7.4. The test tube with the closer was placed in a
water bath maintained at 40C up the lower critical
solution temperature (>LCST), 37C (>LCST). The
release medium (~3 ml) was withdrawn at predetermined
time intervals (1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 24, 36, 48, 70,
90, 110, 120, 170, 180 and 250 h) and after the experi-
ment the samples were analyzed using a UV–vis spec-
trometer (Shimadzu) to determine the amount of
doxorubicin released (λex 470 nm and λem 585 nm for
doxorubicin measurement) [29-31]. The amount of
doxorubicin entrapped efficiency within nanoparticles
was calculated by the difference between the total
amount used to prepare nanoparticles and the amount
of doxorubicin present in the aqueous phase. Loadingefficiency was calculated according to the following
formula: [32].
Loading efficiency % ¼ amount of load drug in mgð Þ




In-vitro cytotoxicity and Cell culture study
A549 lung cancer cell line (kindly dedicated from
pharmaceutical nanotechnology research center, Tabriz
University of Medical Sciences, Tabriz, Iran) were
cultured in RPMI1640 (Gibco, In-vitro gen, UK)
supplemented with 10% heat-inactivated fetal bovine
serum (FBS) (Gibco, Invitrogen, UK), 2 mg/ml sodium
bicarbonate, 0.05 mg/ml penicillin G (Serva co, Germany),
0.08 mg/ml streptomycin (Merck co, Germany) and
incubated in 37C with humidified air containing 5%
CO2. After culturing sufficient amount of cells, cytotoxic
effect of PNIPAAm-MAA-grafted magnetic nanoparticles
was studied by 24, 48 and 72 h MTT assays (Carmichael
et al., 1987). Briefly, 1000 cell/well were cultivated in a 96
well plate (Figure 5). After 24 h incubation in 37C with
humidified atmosphere containing 5% CO2, cells were
treated with serial concentrations of the doxorubicin-
loaded PNIPAAm-MAA-grafted magnetic nanoparticles
(0 mg/ml to 0.57 mg/ml) for 24, 48 and 72 h in the
Figure 5 XRD patterns of (a) pure Fe3O4 nanoparticles.
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extract + 200 μl culture medium containing 10% DMSO
served as control. After incubation, the medium of all
wells of plate were exchanged with fresh medium and cells
were leaved for 24 h in incubator. Then, medium of all
wells were removed carefully and 50 μl of 2 mg/ml MTT
(Sigma co, Germany) dissolved in PBS was added to each
well and plate was covered with aluminum foil and
incubated for 4.5 h. After removing of wells’ content,
200 μl pure DMSO was added to wells. Then, 25 μl
Sorensen’s glycine buffer was added and immediately
absorbance of each well was read in 570 nm using ELx800
Microplate Absorbance Reader (Bio-Tek Instruments)
with reference wavelength of 630 nm [33].Cell treatment
After determination of IC50, 1 × 106 cells were treated
with serial concentrations ofthe doxorubicin-loaded
PNIPAAm-MAA-grafted magnetic nanoparticles (0.028,
0.057, 0.114, 0.142,0.171 and 0.199 mg/ml). For control
cells, the same volume of 10% DMSO without the
doxorubicin-loaded PNIPAAm-MAA-grafted magnetic
nanoparticles was added to flask of control cells. Then,
culture flasks were incubated in 37C containing 5%
CO2 with humidified atmosphere incubator for 24 h
exposure duration.Characterization
The IR spectra were recorded by a Fourier transform infra-
red spectrophotometer (FT-IR, Nicolet NEXUS 670, USA),
and the sample and KBr were pressed to form a tablet. The
magnetization curves of samples were measured with a
vibrating sample magnetometry (VSM, Meghnatis Daghigh
Kavir Co Iran) at room temperature. Powder X-ray diffrac-
tion (XRD, Rigaku D/MAX-2400 X-ray diffractometer with
Ni-filtered Cu Kα radiation) was used to investigate thecrystal structure of the magnetic nanoparticles. The infra-
red spectra of copolymers were recorded on a Perkin
Elmer 983 IR spectrometer (Perkin Elmer, USA) at room
temperature. The size and shape of the nanoparticles were
determined by scaning electron microscope (SEM, VEGA/
TESCAN), the sample was dispersed in ethanol and a
small drop was spread onto a 400 mesh copper grid.Results
Synthesis of poly (NIPAAm-MAA) grafted Fe3O4
nanoparticles
The processes for synthesis of poly (NIPAAm-MAA)-
grafted Fe3O4 nanoparticles and the loading of doxorubi-
cin onto them are shown in Figure 4. The Fe3O4
nanoparticles were prepared by a chemical co-
precipitation of Fe2+ and Fe3+ ions under alkaline condi-
tion. The concentration ratio of Fe2+ /Fe3+ was selected
to be 1:1.8 rather than the stoichiometric ratio of 1:2,
because Fe2+ is prone to be oxidized and become Fe3+ in
solution. The Fe3O4 nanoparticles prepared by the co-
precipitation method have a number of hydroxyl groups
on the surface from contacting with the aqueous phase.
VTES-modified Fe3O4 nanoparticles were achieved by
the reaction between VTES and the hydroxyl groups on
the surface of magnetite. Two reactions were involved in
the process. First, the VTES was hydrolyzed to be highly
reactive silanols species in the solution phase under
alkaline condition. Then, their condensation with sur-
face free -OH groups of magnetite to render stable
Fe–O–Si bonds takes place. Oligomerization of the
silanols in solution also occurs as a competing reac-
tion with their covalent binding to the surface.
Surface-grafted polymerization by NIPAAm and MAA
also involves two reactions, which take place simul-
taneously. On the surface of VTES-modified Fe3O4
nanoparticles, the graft polymerization occurs, while
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order to decrease the random polymerization, the following
strategies were adopted. On the one hand, after AIBN was
dissolved in the modified nanoparticles suspended
solution, the solution was placed overnight to make the
nanoparticles absorb AIBN onto the surface furthest. On
the other side, an optimal concentration of initiator was
selected. In the other work BIS was used as cross-linking
agent and the monomers were added dropwise in the
reaction. The unreacted oligomers would be separated by
magnetic decantation after reaction.
Characterization of Fe3O4 and poly (NIPAAm-MAA)-
grafted Fe3O4 nanoparticles
XRD patterns
Figure 6 shows the XRD patterns of pure Fe3O4. It is
apparent that the diffraction pattern of our Fe3O4
nanoparticles is close to the standard pattern for crystalline
magnetite. The characteristic diffraction peaks marked,
respectively, by their indices (2 2 0), (311), (4 0 0), (4 2 2),
(511), and (4 4 0) could be well indexed to the inverseFigure 6 The SEM micrographs of (a) pure Fe3O4 nanoparticles (b) Fe3
sizes of PNIPAAm-MAA-grafted MNPs.cubic spinel structure of Fe3O4 (JCPDS card no. 85–1436),
were also observed from poly (NIPAAm-MAA)-grafted
Fe3O4 nanoparticles. This reveals that modified and grafted
polymerized, on the surface of Fe3O4 nanoparticles, did
not lead to their crystal phase change. The average crystal-
lite size D was about 15 nm, obtained from Sherrer equa-
tion D =Kλ/ (βcos θ), where K is constant, λ is X-ray
wavelength, and β is the peak width of half-maximum.
Size, morphology, and core-shell structure of nanoparticles
The SEM micrographs of pure Fe3O4 nanoparticles
(Figure 6 (a)) and Fe3O4 nanoparticles grafted by poly
(NIPAAm-MAA) (Figure 6 (b)) are shown. Observing the
photograph (a), nanoparticles were aggregated seriously,
which was due to the nanosize of the Fe3O4, and they were
about 20–75 nm, according to the result of XRD. After
graft polymerization, the size of particles was changed to be
60–100 nm, and the dispersion of particles was improved
greatly (Figure 6 (b)), which can be explained by the
electrostatic repulsion force and steric hindrance between
the polymer chains on the surface of Fe3O4 nanoparticles.O4 nanoparticles grafted by poly-(NIPAAm-MMA) (c) Hydrodynamic
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To evaluate the effect of graft polymerization, the
homopolymers and unreacted monomers were extracted
in ethanol to be separated from the grafted nanoparticles.
FT-IR spectroscopy was used to show the structure of
Fe3O4 (Figure 7 (a)), VTES-modified Fe3O4 (Figure 7 (b))
and poly (NIPAAm-MAA)-grafted Fe3O4 (Figure 7(c)).
From the IR spectra presented in Figure 8, the absorption
peaks at 568 cm-1 belonged to the stretching vibration
mode of Fe–O bonds in Fe3O4. Comparing with the IR
spectrum (a), the IR spectrum (b) of VTES-modified
Fe3O4 possessed absorption peaks presented at 1603 and
1278 cm-1 should be attached to the stretching vibrations
of C = C and the bending vibration of Si–C bonds, peak at
1411 cm-1 due to the bending vibration of = CH2 group,
additional peaks centered at 1116, 1041, 962 and 759 cm-1
were most probably due to the symmetric and asym-
metric stretching vibration of framework and terminal
Si–O– groups. All of these revealed the existence of
VTES. It indicated that the reactive groups had been
introduced onto the surface of magnetite. The absorptionFigure 7 FT-IR spectra of (a) pure Fe3O4 nanoparticles, (b) Fe3O4 nan
Fe3O4 nanoparticles.peaks of C = C and = CH2 groups disappeared, and add-
itional peaks at 1724, 1486, 1447 and 1387 cm-1 due to
the stretching vibrations of C =O, the bending vibration
of –CH2–, –CH– and –CH3 absorption peaks at 1147,
906 and 847 cm-1 belonged to the stretching vibration of
the alkyl groups fromNIPAAm. However, the identifi-
cation of peak attributable to the stretching vibrations
of C–N (normally at about 1100 cm-1) was problematic due
to overlapping other peaks, but the element analysis
method demonstrated the presence of N element of the
NIPAAm in poly (NIPAAm-MAA)-grafted Fe3O4 nano-
particles. Overall, these FT-IR spectra provided supportive
evidence that the –CH=CH2 group initiated polyme-
rization of NIPAAm and MAA polymer chains were
successfully grafted onto the Fe3O4 nanoparticles surface.
Magnetism test
The magnetic properties of the magnetic nanoparticles
were analyzed by VSM at room temperature. Figure 8
shows the hysteresis loops of the samples. The saturation
magnetization was found to be 34.5 and 17.6 emu/g foroparticles modified by VTES, (c) poly(NIPAAm-MMA)-grafted
Figure 8 The magnetic behavior of magnetic nanoparticles. (1.Fe3O4, 2. VTES-Fe3O4, 3. VTES-Fe3O4-PNIPAAm-MAA).
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Fe3O4, respectively, less than the pure Fe3O4 nanoparticles
(70.9 emu/g). With the large saturation magnetization, the
poly (NIPAAm-MAA)-grafted Fe3O4 could be separated
from the reaction medium rapidly and easily in a
magnetic field. In addition, there was no hysteresis in
the magnetization with both remanence and coercivity
being zero, suggesting that these magnetic nanoparticles
were superparamagnetic. When the external magnetic field
was removed, the magnetic nanoparticles could be well
dispersed by gentle shaking. These magnetic properties
were critical in the applications of the biomedical and
bioengineering fields.
In vitro release experiment
The release behavior of the nanoparticles was studied
for ~200 hours in PBS (0.1 M, pH 7.4, 5.8) at 37C, and
40C. The percentage of cumulative release of doxorubicin
at 40C was significantly higher than at 37C (Figure 9).
The pH-responsive release profiles from the hybrid
nanoparticles are shown in Figure 10 (pH 5.8, and 7.4).
The release rate decreased with the increase of pH values.
The pKa value of the amino group in doxorubicin is about
8.2. Thus the electrostatic interaction existed at neutral
surrounding and disappeared at acid surrounding. The pH
value of the tumor was 5.0–6.0, which was lower than the
pH value of the normal tissue, so the doxorubicin on
hybrid nanoparticles could be released at the tumor.
In-vitro cytotoxicity study of doxorubicin-loaded
PNIPAAm-MAA-grafted magnetic nanoparticles on A549
lung cancer cell line
MTT assay is an important method to evaluate the in-
vitro cytotoxicity of biomaterials. In MTT assay, theabsorbance is in a significant linear relationship with cell
numbers. The corresponding optical images of cells are
shown in Figure 10. In the current work, MTT assay
showed that doxorubicin-loaded PNIPAAm-MAA-grafted
magnetic nanoparticles has time-dependent but not dose-
dependent cytotoxicity on the A549 lung cancer cell line
(IC50 = 0.16 to 0.20 mg/ml). Also, MTT assay showed that
pure doxorubicin has dose-dependent but not time-
dependent cytotoxicity on the A549 lung cancer cell line
(IC50 = 0.15 to 0.16 mg/ml). Therefore, there is need for fur-
ther study of doxorubicin-loaded PNIPAAm-MAA-grafted
magnetic nanoparticles on A549 lung cancer cell line in
the future. However, results of current work demonstrated
that IC50 of doxorubicin-loaded PNIPAAm-MAA-grafted
magnetic nanoparticles and pure doxorubicin are about
0.16, 0.20 mg/ml and 0.15 mg/ml respectively, in A549
lung cancer cell line.
Discussion
In this work we have characterized in vitro behavior of
Poly NIPAAm-MAA-grafted magnetic nanoparticles for
targeted and controlled drug delivery applications. The
XRD data only showed peaks attributable to magnetite
(Fe3O4) and discovered that grafted polymerized, on the
surface of Fe3O4 nanoparticles, did not lead to their
crystal phase transform. FT-IR spectroscopy was used to
show the structure of Fe3O4, VTES-modified Fe3O4 and
poly (NIPAAm-MAA)-grafted Fe3O4. The saturation
magnetization was found to be 34 and 17 emu/g for
VTES-modified Fe3O4 and poly(NIPAAm-MAA)-grafted
Fe3O4, respectively, less than the pure Fe3O4 nanoparticles
(70.9 emu/g) by VSM. This difference suggests that a large
amount of silane and polymers grafted on the surface
of Fe3O4 nanoparticles. The size and morphology of the
Figure 9 Release profiles of doxorubicin from the hybrid nanoparticles at different pH /temperature values.
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method was carried out to study the core shell structure,
morphology, and size of the nanoparticles. A close exam-
ination of the SEM image (Figure 6) reveals the presence
of magnetic nanoparticles (~10 nm diameter) at the
center with a PNIPAAm-MAA coating surrounding
them. The size of the magnetic core was similar to earlier
reported values of magnetic nanoparticles synthesized by
similar methods [34]. In comparison with PNIPAAm-
grafted magnetic nanoparticles [35], there was clearly less
agglomeration of magnetic nanoparticles in the core.
This might be a result of the higher mixing capability due
to utilization of a mechanical stirrer and the electrostatic
charge repulsion from the carboxylic group of MAA inthe PNIPAAm-MAA coating, which would further reduce
the magnetic dipole interactions and promote stability
[36]. We believe that grafting magnetic nanoparticles with
a biocompatible copolymer is necessary when high
concentrations of magnetic nanoparticles are used.
The drug release study indicates that the Poly NIPAAm-
MMA is a temperature-sensitive polymer, whereby at
its lower critical solution temperature (LCST) the
nanoparticles go through the phase change to fall
down and release more drugs. After 250 hours, 55% of
the bonded doxorubicin was released at 40C, whereas
at 37C ~40% was released. The release profile of the
doxorubicin over the first 40 minutes is also shown in
Figure 9. After 40 minutes the percentages of growing
Figure 10 IC50 of (a) the doxorubicin-loaded linear PNIPAAm-MAA-grafted magnetic nanoparticles (b) the doxorubicin-loaded cross
linker PNIPAAm-MAA-grafted magnetic nanoparticles (c) Pure doxorubicin on A549 tumor cell line after 24, 48 and 72 h treatment.
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whereas at 40C it was 2.5%. The system is shown to
release its payload over a short burst release period
with changes in temperature. Since the measurement
time was very short while the drug release fixed time
interval was significantly large, the influence of the
returned medium on drug release during the measure-
ment time is expected to be insignificant [37]. The
doxorubicin release profiles from our nanoparticles
established that our nanoparticles xwere responsive to
temperature with a significantly higher release at 40C
than at 37C. The in-vitro cytotoxicity test showed
that the doxorubicin-loaded PNIPAAm-MAA-grafted
magnetic nanoparticles had no cytotoxicity and were
biocompatible, which means there is potential for
biomedical application [38]. Also IC50 of doxorubicin-
loaded PNIPAAm-MAA-grafted magnetic nanoparticles
on A549 lung cancer cell line showed that they are
time-dependent.Conclusions
SPIONs were synthesised via co-precipitation method
and then Fe3O4 nanoparticles were grafted by
Vinyltriethoxysilicane, and created reactive groups onto
the nanoparticles’ surface therefore, NIPAAm and MAA
were bonded onto the surface of modified-Fe3O4
nanoparticles by surface initiated radical polymerization
with presence and without presence cross linker. The
results indicate that the copolymer chains had been
effectively encapsulated Fe3O4 nanoparticles and effect-
ively grafted onto the surface of Fe3O4 nanoparticles.
The functionalized particles remained dispersive and
superparamagnetic. These particles were employed in
encapsulation of doxorubicin under mild conditions and
could significantly used in the drug delivery. The resul-
tant particles were characterized by vibrating sample
magnetometry (VSM), Fourier transform infrared spec-
troscopy (FT-IR), Scanning electron microscopy (SEM),
and X-ray powder diffraction (XRD). The in vitro
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http://www.jnanobiotechnology.com/content/10/1/46cytotoxicity study demonstrated that the grafted-Fe3O4
nanoparticles had no cytotoxicity and were biocompatible.
This study suggests that supercritical fluid technology is a
promising technique to produce drug-copolymer mag-
netic composite nanoparticles for the design of drug
controlled release systems. Current work demonstrated that
doxorubicin-loaded with modified-Fe3O4 nanoparticles has
potent anti-growth effect on A549 and time-dependently
inhibits cell growth in this cell line. As a result, these
nanoparticles can be normal potent chemotherapeutic
agent for lung cancer patients and constituents of
these nanoparticles can be suitable candidate for drug
development [39-42].
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